language_icon
EN
HI

Invicta Diagnostic Share price

INVICTA

65

3.00 (-4.41%)
Last updated on 2 Jun, 2026 | 15:25 IST
Today's High

67.60

Today's Low

65.00

52 Week Low

58.10

52 Week High

105.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Invicta Diagnostic Chart

Invicta Diagnostic Share Key Metrics

Volume
16000.00
Market Cap
85.49 CR
LTQ@LTP
1600@65.00
ATP
65.59
Var Margin
100 %
Circuit Range
64.6-71.4
Delivery %
88.89 %
Value
10.49 L
ASM/GSM
No
Market Lot
1600

Summary

Invicta Diagnostic share price is ₹65 as of 2 Jun, 2026. The stock Invicta Diagnostic intraday movement has stayed between ₹65.00 and ₹67.60, while on a 52-week basis,Invicta Diagnostic price 52 week high is ₹105.00 & its 52 week low is ₹58.10.
In terms of trading activity, Invicta Diagnostic has recorded a volume of 16000 shares, The Invicta Diagnostic has a market cap of ₹12571973 CR. The stock’s Average Traded Price (ATP) stands at ₹65.59, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1600 @ ₹65.00.
Invicta Diagnostic operates within a circuit range of ₹64.60 – ₹71.40, with a Value of ₹10.49 L. The Delivery Percentage for the day is 88.89%. Additionally, Invicta Diagnostic currently falls under the No framework, and trades with a market lot size of 1600.

Invicta Diagnostic Fundamentals

View More
P/E Ratio

17.43

P/B Ratio

1.66

Div. Yield

0

Sector P/E

55.05

Sector P/B

-15.49

Sec. Div. Yield

0.18

Invicta Diagnostic Resistance and Support

Pivot 66.73

Resistance

First Resistance

69.26

Second Resistance

70.53

Third Resistance

73.06

Support

First Support

65.46

Second Support

62.93

Third Support

61.66

Invicta Diagnostic Shareholding Pattern

View More
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

66.7%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

4.2%

Domestic Institutional Investors

4.3%

Retail

24.81%

Others

-0.01%

Total Promoters
MAR '26
66.7%

Invicta Diagnostic Corporate Actions

DateAgenda
2026-05-18Audited Results

Invicta Diagnostic News

Invicta Diagnostic Limited

Invicta Diagnostic Ltd's Audit Committee reviewed the statement of deviation in IPO fund utilization for FY26, confirming no deviation for the period. Shareholders have approved future deviations which will be reported subsequently.
May 29 2026 12:53:34

Invicta Diagnostic Limited

Invicta Diagnostic hosted its H2 FY26 earnings call, where management outlined strategic expansion into new geographies like Pune and Shegaon, alongside the acquisition of Vinchurkar Diagnostics for INR7.6 crores. The company also detailed its full-year FY26 income of INR33.04 crores and net profit of INR4.87 crores, emphasizing a focus on long-term EBITDA growth despite short-term margin pressures from new center ramp-up.
May 25 2026 20:23:47

Invicta Diagnostic Limited

Invicta Diagnostic Limited has launched tele-radiology services for clients in the United States, expanding its international diagnostic reporting capabilities. This move aims to enhance patient care by offering timely and accurate reporting to a broader healthcare network globally.
May 22 2026 12:26:51

Invicta Diagnostic Limited

Invicta Diagnostic Limited's Board of Directors will hold a meeting on May 18, 2026. The primary agenda is to consider and approve the audited standalone and consolidated yearly financial results for the period ended March 2026.
May 13 2026 20:49:48

Invicta Diagnostic Limited

Invicta Diagnostic's board will convene on May 18, 2026, to consider and approve the standalone and consolidated audited financial results for the fiscal year ended March 31, 2026. This meeting is a routine announcement for annual financial disclosures.
May 13 2026 20:48:40

Invicta Diagnostic Limited

Invicta Diagnostic has completed the acquisition of a 51% stake in Vinchurkar Diagnostics Private Limited. This is the first tranche of a proposed 95% acquisition, with the total cash consideration for 95% being Rs. 7.60 crores.
May 08 2026 20:12:03

Invicta Diagnostic Limited

Invicta Diagnostic Limited has completed the acquisition of a 51% majority stake in Vinchurkar Diagnostics Private Limited. This strategic move strengthens the company's presence in the diagnostics sector.
May 08 2026 19:49:21
Read More

Invicta Diagnostic Management

NamePosition
Ketan Jayantilal JainNon Executive Director
Sanket Vinod JainChairman
View More

Invicta Diagnostic FAQs

The Buying Price of Invicta Diagnostic share is 65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Invicta Diagnostic stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Invicta Diagnostic, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Invicta Diagnostic shares is 17.43. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Invicta Diagnostic shares is 1.66. Useful to assess the stock's value relative to its book value.

To assess Invicta Diagnostic’s valuation compare Sector P/E, P/B which are 55.05 & -15.49 with sector averages, along with growth rates and financial metrics.

The Market Cap of Invicta Diagnostic is 85.49 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Invicta Diagnostic share price is 105.00 & 58.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Invicta Diagnostic belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost